OBJECTIVES: To determine the safety and oncological advantages of en bloc resection of bladder tumour (ERBT) vs conventional transurethral resection of bladder tumour (cTURBT) in terms of resection quality, staging quality, and safety. PATIENTS AND METHODS: We conducted a single-blinded randomised controlled trial at seven European hospitals with the following inclusion criteria: first diagnosis of non-muscle-invasive bladder cancer, no singular carcinoma in situ, and tumour size >4.3 mm. Patients were randomised intraoperatively in a 1:1 ratio to either the ERBT or cTURBT group. Outcome analysis was performed using the chi-square test, t-test, and multivariate regression analysis. RESULTS: A total of 97 patients were randomised into the study (cTURBT = 40, ERBT = 57). A switch to cTURBT was necessary in two patients (3.5%) and 11.5% of the screened patients were preoperatively excluded for ERBT. There was no difference in the specimen presence of detrusor muscle with 73.7% in cTURBT and 67.3% in ERBT specimens (P = 0.69). There were no significant differences in mean operative time (ERBT 27.6 vs cTURBT 25.4 min, P = 0.450) or mean resection time (ERBT 16.3 vs cTURBT 15.5 min, P = 0.732). Overall the complication rate did not differ significantly (ERBT 18.2% vs cTURBT 7.5%, P = 0.142). Bladder perforations occurred significantly more often in the ERBT group (ERBT seven vs cTURBT none, P = 0.020). R0 status was reported more often after ERBT, whilst a second resection was significantly less frequent after ERBT (P = 0.018). Recurrence rates were comparable for both techniques after 6 months of follow-up. CONCLUSION: The feasibility of ERBT is higher than previously reported. Whereas other perioperative and safety parameters are comparable to cTURBT, bladder perforations occurred significantly more often in the ERBT group and raised safety concerns. This is why this trial was terminated.

Department of Urology and Andrology Salzburg University Hospital Salzburg Austria

Department of Urology and Pediatric Urology SLK Klinikum Heilbronn Germany

Department of Urology and Urologic Surgery University Medical Centre Mannheim Mannheim Germany

Department of Urology Brandenburg Medical School Theodor Fontane Brandenburg an der Havel Germany

Department of Urology of the 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Urology Ospedale Civile S Agostino Estense Modena Italy

Department of Urology Protest and Hospital Königin Elisabeth Herzberge Berlin Germany

Department of Urology University Hospital Schleswig Holstein Lübeck Germany

Department of Urology Wolfsburg Hospital Wolfsburg Germany

Motol University Hospital Prague Czech Republic

See more in PubMed

Babjuk M, Burger M, Compérat E, Gontero P, Liedberg F. EAU Guidelines on non‐muscle‐invasive bladder cancer (TaT1 and CIS). 2021.

Adachi H, Ito H, Sawabata N. Circulating tumor cells and the non‐touch isolation technique in surgery for non‐small‐cell lung cancer. Cancer 2022; 14: 1448 PubMed PMC

Truong M, Liang L, Kukreja J, O'Brien J, Jean‐Gilles J, Messing E. Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours. Can Urol Assoc J 2017; 11: E203–E206 PubMed PMC

Magers MJ, Lopez‐Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Staging of bladder cancer. Histopathology 2019; 74: 112–134 PubMed

Rouprêt M, Seisen T, Compérat E et al. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French National Multicenter Study with central pathology review. J Urol 2013; 189: 2069–2076 PubMed

Teoh JYC, MacLennan S, Chan VWS et al. An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two‐round Delphi survey, and a consensus meeting. Eur Urol 2020; 78: 546–569 PubMed

Sylvester RJ, van der Meijden APM, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466–477 PubMed

American Society of Anesthesiologists . ASA physical status classification system. Chicago: American Society of Anesthesiologists, 2020.

Kramer MW, Altieri V, Hurle R et al. Current evidence of transurethral en‐bloc resection of nonmuscle invasive bladder cancer. Eur Urol Focus 2017; 3: 567–576 PubMed

Gakis G, Karl A, Bertz S et al. Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non‐muscle‐invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial. BJU Int 2020; 126: 509–519 PubMed

D'Andrea D, Soria F, Hurle R et al. En bloc versus conventional resection of primary bladder tumor (eBLOC): a prospective, multicenter, open‐label, phase 3 randomized controlled trial. Eur Urol Oncol 2023; 6: 508–515 PubMed

Yuen‐Chun Teoh J, Cheng CH, Tsang CF et al. Transurethral en bloc resection versus standard resection of bladder tumour: a randomised, multicentre, phase 3 trial. Eur Urol 2024; 86: 103–111 PubMed

Gallioli A, Diana P, Fontana M et al. En bloc versus conventional transurethral resection of bladder tumors: a single‐center prospective randomized noninferiority trial. Eur Urol Oncol 2022; 5: 440–448 PubMed

Hurle R, Lazzeri M, Colombo P et al. “En bloc” resection of nonmuscle invasive bladder cancer: a prospective single‐center study. Urology 2016; 90: 126–130 PubMed

Naselli A, Puppo P. En bloc transurethral resection of bladder tumors: a new standard? J Endourol 2017; 31(S1): S‐20–S‐24 PubMed

Teoh JYC, Mayor N, Li KM, Lo KL, Ng CF, Mostafid H. En‐bloc resection of bladder tumour as primary treatment for patients with non‐muscle‐invasive bladder cancer: routine implementation in a multi‐centre setting. World J Urol 2021; 39: 3353–3358 PubMed

Li K, Xu Y, Tan M, Xia S, Xu Z, Xu D. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non‐muscle invasive bladder cancer. Lasers Med Sci 2019; 34: 85–92 PubMed

Kramer MW, Rassweiler JJ, Klein J et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015; 33: 1937–1943 PubMed

Breda A, Gallioli A, Diana P et al. The DEpth of endoscopic perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial. World J Urol 2022; 41: 2583–2589 PubMed PMC

Bebane S, Denize J, Goujon A et al. Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria. World J Urol 2021; 39: 4159–4165 PubMed

Chen J, Zhao Y, Wang S et al. Green‐light laser en bloc resection for primary non‐muscle‐invasive bladder tumor versus transurethral electroresection: a prospective, non randomized two‐center trial with 36‐month follow‐up. Lasers Surg Med 2016; 48: 859–865 PubMed